VC
AUPH icon

Vivo Capital’s Aurinia Pharmaceuticals AUPH Stock Holding History

Vivo Capital’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-500,732
Closed -$11.1M – 57
2021
Q3 		$11.1M Hold
500,732
– – 0.5% 35
2021
Q2 		$6.49M Hold
500,732
– – 0.28% 49
2021
Q1 		$6.5M Hold
500,732
– – 0.23% 52
2020
Q4 		$6.92M Hold
500,732
– – 0.31% 46
2020
Q3 		$7.38M Hold
500,732
– – 0.43% 46
2020
Q2 		$8.14M Hold
500,732
– – 0.58% 36
2020
Q1 		$7.27M Buy
+500,732
New +$8.83M 0.66% 36
2019
Q3 		– Sell
-1,913,623
Closed -$12.6M – 11
2019
Q2 		$12.6M Buy
1,913,623
+700,333
+58% +$4.46M 1.18% 23
2019
Q1 		$7.89M Hold
1,213,290
– – 0.79% 33
2018
Q4 		$8.28M Hold
1,213,290
– – 1.06% 26
2018
Q3 		$8.06M Hold
1,213,290
– – 0.81% 29
2018
Q2 		$6.83M Hold
1,213,290
– – 0.88% 27
2018
Q1 		$6.3M Hold
1,213,290
– – 0.89% 21
2017
Q4 		$5.5M Hold
1,213,290
– – 1.18% 19
2017
Q3 		$7.61M Buy
1,213,290
+200,141
+20% +$1.26M 1.54% 17
2017
Q2 		$6.21M Buy
1,013,149
+413,149
+69% +$2.78M 1.56% 14
2017
Q1 		$4.4M Buy
+600,000
New +$2.77M 1.3% 14

Other funds holding AUPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
MAM
Melqart Asset Management London, United Kingdom $1.01B AUM 84.85% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Vivo Capital's AUPH Position: Q4 2021 in Review

Vivo Capital sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2021, closing a stake of 500,732 shares — an estimated $11.1M sold.

Vivo Capital first reported a position in AUPH in Q1 2017 and held it in 17 quarters. The position peaked at $12.6M in Q2 2019. 190 funds tracked by Wall St. Rank hold AUPH as of Q4 2021.

  • Vivo Capital reported no remaining Aurinia Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Vivo Capital sold 500,732 Aurinia Pharmaceuticals shares in Q4 2021, an estimated $11.1M.
  • Vivo Capital first reported a position in Aurinia Pharmaceuticals in Q1 2017 and held it in 17 quarters.
  • Vivo Capital's Aurinia Pharmaceuticals position peaked at $12.6M in Q2 2019.
  • 190 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2021.

Based on Vivo Capital's 13F filing for Q4 2021, filed 11 Feb 2022.